Targeted Therapies

Our pipeline emphasizes high value potential first-in-class biologics focused on dysregulated inflammation via the LIGHT-signaling network.

Pipeline

Clinical Stage Pipeline

We are advancing a pipeline that emphasizes high value potential first-in-class biologics focused on dysregulated inflammation via the LIGHT-signaling network.